GREAT WEST LIFE ASSURANCE CO /CAN/ - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 258 filers reported holding HAEMONETICS CORP in Q4 2021. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.

Quarter-by-quarter ownership
GREAT WEST LIFE ASSURANCE CO /CAN/ ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q3 2023$3,580
+13.9%
40,000
+8.5%
0.01%
+28.6%
Q2 2023$3,144
-6.2%
36,883
-8.9%
0.01%
-12.5%
Q1 2023$3,351
+2.2%
40,490
-2.7%
0.01%
-11.1%
Q4 2022$3,280
-99.9%
41,634
+18.3%
0.01%
+28.6%
Q3 2022$2,606,000
+28.1%
35,202
+12.7%
0.01%
+40.0%
Q2 2022$2,034,000
+12.2%
31,223
+12.0%
0.01%
+25.0%
Q1 2022$1,813,000
+32.1%
27,886
+7.8%
0.00%
+33.3%
Q4 2021$1,372,000
-19.3%
25,868
+8.1%
0.00%
-25.0%
Q3 2021$1,701,000
+32.3%
23,922
+23.9%
0.00%
+33.3%
Q2 2021$1,286,000
-41.1%
19,303
-2.1%
0.00%
-40.0%
Q1 2021$2,185,000
-13.4%
19,707
-7.2%
0.01%0.0%
Q4 2020$2,522,000
+21.2%
21,242
-10.9%
0.01%0.0%
Q3 2020$2,080,000
-8.2%
23,847
-5.8%
0.01%0.0%
Q2 2020$2,266,000
-13.8%
25,308
-4.2%
0.01%
-28.6%
Q1 2020$2,630,000
-6.1%
26,426
+7.6%
0.01%
+16.7%
Q4 2019$2,800,000
-21.0%
24,564
-16.6%
0.01%
-25.0%
Q2 2019$3,543,000
+27.8%
29,453
-7.1%
0.01%
+14.3%
Q1 2019$2,773,000
-6.4%
31,712
-0.6%
0.01%
-12.5%
Q4 2018$2,962,000
-14.1%
31,900
+6.0%
0.01%0.0%
Q3 2018$3,448,000
+24.7%
30,088
-2.4%
0.01%
+33.3%
Q2 2018$2,764,000
-46.3%
30,820
-56.2%
0.01%
-50.0%
Q1 2018$5,143,000
+29.0%
70,291
+2.3%
0.01%
+33.3%
Q4 2017$3,988,000
+27.8%
68,681
-4.9%
0.01%
+12.5%
Q3 2017$3,120,000
+2.9%
72,189
-6.1%
0.01%0.0%
Q2 2017$3,033,000
+1.3%
76,839
+4.1%
0.01%0.0%
Q1 2017$2,993,000
+8.2%
73,789
+7.2%
0.01%0.0%
Q4 2016$2,767,000
-45.2%
68,803
-50.7%
0.01%
+14.3%
Q3 2016$5,052,000
+161.0%
139,596
+109.0%
0.01%
+16.7%
Q2 2016$1,936,000
+772.1%
66,787
+949.8%
0.01%
+500.0%
Q1 2016$222,000
+8.3%
6,3620.0%0.00%0.0%
Q4 2015$205,000
-0.5%
6,3620.0%0.00%0.0%
Q3 2015$206,000
+32.9%
6,362
+69.1%
0.00%0.0%
Q2 2015$155,000
-7.7%
3,7620.0%0.00%0.0%
Q1 2015$168,000
+20.0%
3,7620.0%0.00%
Q4 2014$140,000
+6.1%
3,7620.0%0.00%
Q3 2014$132,0000.0%3,7620.0%0.00%
Q2 2014$132,000
+8.2%
3,7620.0%0.00%
Q1 2014$122,000
-23.8%
3,7620.0%0.00%
-100.0%
Q4 2013$160,0003,7620.00%
Other shareholders
HAEMONETICS CORP shareholders Q4 2021
NameSharesValueWeighting ↓
LGT CAPITAL PARTNERS LTD. 1,216,059$64,500,0001.72%
HEARTLAND ADVISORS INC 406,192$21,544,0001.26%
KINGDON CAPITAL MANAGEMENT, L.L.C. 200,000$10,608,0001.22%
Aurora Investment Counsel 32,149$1,705,0001.01%
Endurant Capital Management LP 73,914$3,920,0000.95%
KINGDON CAPITAL MANAGEMENT, L.L.C. 135,000$7,160,0000.82%
ARMISTICE CAPITAL, LLC 872,000$46,251,0000.76%
Summit Creek Advisors LLC 131,357$6,967,0000.70%
Dean Capital Management 15,309$812,0000.70%
Keene & Associates, Inc. 11,720$622,0000.54%
View complete list of HAEMONETICS CORP shareholders